While these drugs were FDA-approved for diabetes treatment and, in limited cases, for weight loss management, many doctors prescribed them more broadly without adequately warning patients of the potential risks
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinsons disease (the ADAGIO study): rationale, design, and baseline characteristics
Neurogen Research offers this premium blend with over 99% purity
Whether youre beginning your peptide therapy journey or looking to enhance existing protocols, our team provides the guidance, support, and pharmaceutical-grade compounds necessary to achieve lasting wellness transformation throughout Orange Countys vibrant communities.